IMM

ImmuPharma Q&A: More positive news will continue to strengthen share price (LON:IMM)

ImmuPharma's Tim McCarthy discusses their licencing & development agreement with Avion, the Lanstead deal and the key investment points for investing in IMM in this exclusive interview with DirectorsTalk...
Search

Funds

Investor Presentations

ImmuPharma Q&A: More positive news will continue to strengthen share price (LON:IMM)

ImmuPharma's Tim McCarthy discusses their licencing & development agreement with Avion, the Lanstead deal and the key investment points for investing in IMM in this exclusive interview with DirectorsTalk...
Search

Funds

IMM

FTSE 100

Funds